Ultra-Low Anti-Müllerian Hormone Levels in Recurrent Cystic Ovarian Neoplasm: A Case Report
DOI:
https://doi.org/10.24293/ijcpml.v30i3.1940Keywords:
Αnti-Müllerian hormone, ovarian neoplasm, ovarian cysts, fertility, case reportAbstract
Fertility has been a major issue in the management of cystic ovarian neoplasm. This case report presents an extreme case of ultra-low AMH levels in a young female with recurrent cystic ovarian neoplasm and analyzes the potential causes. A twenty-two-year-old female presented with stomach discomfort. The patient had undergone two surgeries for ovarian neoplasm within the last six years. The patient had another abdominal lump suspected to be a residual tumor mass. After further examination, the patient was diagnosed with cystic ovarian neoplasm. The laboratory findings showed low T4 levels, increased TSH levels, and ultra-low AMH levels (0.023 ng/mL). Management of cystic ovarian neoplasm should concern the effect on fertility. The AMH level can be used for pre-treatment counseling in these patients.
Downloads
References
Mobeen S, Apostol R. Ovarian cyst. [Updated 2023 June 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560541/ (accessed March 19, 2024).
Huang J, Chan WC, Ngai CH, Lok V, Zhang L, et al. Worldwide burden, risk factors, and temporal trends of ovarian cancer: A global study. Cancers (Basel), 2022; 14(9): 2230.
Mukta SA, Islam S, Akter S, Rikta SA. Prevalence and risk factors of ovarian cysts in women aged 18-45 years in Bangladesh: A prospective study on ovarian cyst development and carcinoma risk. ARJGO, 2023; 6(1): 221-6.
Iavazzo C, Vorgias G, Iavazzo PE, Gkegkes ID. Fertility-sparing approach as the standard of care in young patients with immature teratomas. J Turk Ger Gynecol Assoc, 2017; 18(1): 43-47.
Mohamed AA, Al-Hussaini TK, Fathalla MM, El Shamy TT, Abdelaal II, Amer SA. The impact of excision of benign nonendometriotic ovarian cysts on ovarian reserve: A systematic review. Am J Obstet Gynecol, 2016; 215(2): 169-76.
Lind T, Hammarström M, Lampic C, Rodriguez-Wallberg K. Anti-Müllerian hormone reduction after ovarian cyst surgery is dependent on the histological cyst type and preoperative anti-Müllerian hormone levels. Acta Obstet Gynecol Scand, 2015; 94(2): 183-90.
Oh SR, Choe SY, Cho YJ. Clinical application of serum anti-Müllerian hormone in women. Clin Exp Reprod Med, 2019; 46(2): 50-9.
Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, et al. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer, 2018; 142(2): 262-270.
Zhao F, Yao H H-C. A tale of two tracts: History, current advances, and future directions of research on sexual differentiation of reproductive tracts. Biol Reprod, 2019; 101(3): 602–16.
Park SH, Chung YJ, Song JY, Kim SI, Pepin D, et al. Müllerian inhibiting substance inhibits an ovarian cancer cell line via B-catenin interacting protein deregulation of the Wnt signal pathway. Int J Oncol, 2017; 50: 1022-8.
Chauvin M, Garambois V, Colombo PE, Chentouf M, Gros L, et al. Anti-Müllerian Hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells. Sci Rep, 2021; 2231.
Fortner R, Schock H, Jung S, Allen NE, Arslan AA, et al. Anti-Müllerian hormone and endometrial cancer: A multi-cohort study. Br J Cancer, 2017; 1412–1418.
Kuroda K, Uchida T, Nagai S, Ozaki R, Yamaguchi T, Sato Y, Brosens JJ, Takeda S. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age. J Assist Reprod Genet, 2015; 32(2): 243-7.
Meng L, Rijntjes E, Swarts HJ, Keijer J, Teerds KJ. Prolonged hypothyroidism severely reduces ovarian follicular reserve in adult rats. J Ovarian Res, 2017; 10(1): 19.
Zaghloul YI, Amin YM, Mansour RT, Serour A, Aboulghar MM, et al. Live birth rate after IVF/ICSI in women with low and extremely low AMH: An age-matched controlled study. Middle East Fertil Soc J, 2020; 25(2): 1-6.
Vale-Fernandes E, Barreiro M, Leal C, Macedo RZ, Tomé A, Monteiro MP. Elevated anti-Müllerian hormone as a prognostic factor for poor outcomes of in vitro fertilization in women with polycystic ovary syndrome. Biomedicines, 2023; 11(12): 3150.
Seifer DB, Tal O, Wantman E, Edul P, Baker VL. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum anti-Müllerian hormone: A multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic outcome reporting system database for 2012-2013. Fertil Steril, 2016; 105(2): 385-93. e3.
Haghgoo A, Shervin A, Chaichian S, Ghahremani M, Mehdizadeh Kashi A, Akhbari F. Increasing trend of serum antimullerian hormone level after long term follow up of endometrioma resection. J Endomet Pelvic Pain Disorders, 2021; 13(2): 98-103.
Anh ND, Ha NTT, Tri NM, Huynh DK, Dat DT, et al. Long-term follow-up of anti-Müllerian hormone levels after laparoscopic endometrioma cystectomy. Int J Med Sci, 2022; 19(4): 651-8.
Pais AS, Flagothier C, Tebache L, Almeida Santos T, Nisolle M. Impact of surgical management of endometrioma on AMH levels and pregnancy rates: A review of recent literature. J Clin Med, 2021; 10(3): 414.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
